- Past Issues
- e-Submission
-
2021 Impact Factor 1.766
5-Year Impact Factor 1.674
Editorial Office
- +82-01-9989-7744
- kbiolpsychiatry@gmail.com
- https://www.biolpsychiatry.or.kr/
2021 Impact Factor 1.766
5-Year Impact Factor 1.674
Korean Journal of Biological Psychiatry 2009;16(2):112-20. Published online: Feb, 1, 2009
Objectives:Depression is a common psychiatric disorder in cancer patients. The
Brief Edinburgh Depression Scale(BEDS), which is an abbreviated version of the
Edinburgh Depression Scale, may serve as a useful tool in screening for the
depression in patients with the medical illnesses. This report investigated the
reliability and validity of the Korean Version of the BEDS(K-BEDS) for the
depression in cancer patients.
Methods:One-hundred cancer patients were enrolled in this study. All subjects
completed the K-BEDS, the Hospital Anxiety Depression Scale(HADS), and the
Karnofsky Performance Status Scale(KPSS). Reliability, validity and Receiver
Operating Characteristic(ROC) curve analysis measures were assessed.
Results:The K-BEDS showed good internal consistency(Cronbach α=0.77) and
test-retest reliability(0.94, p<0.001). All item-total correlations were above
0.3. Also, it revealed moderate correlation with the depression subscale of the
HADS(r=0.617), but no correlation with the KPSS. Exploratory factor analysis
produced only one factor, accounting for 47.1% of the total variance. The most
valid cutoff value to screen for depression was a total score of 5 on the
K-BEDS, which showed sensitivity of 62.5% and specificity of 86.4% with a
positive predictive value of 4.60 and a negative predictive value of 0.43.
Conclusion:The present findings suggested that the K-BEDS would have good
psychometric properties to screen for the depression in cancer patients.
Keywords Brief edinburgh depression scale;Cancer;Depression;Reliability;Validity;Cutoff value.